Cite
HARVARD Citation
Saraux, A. et al. (n.d.). FRI0116 SUBCUTANEOUS TOCILIZUMAB IN MONOTHERAPY OR IN COMBINATION WITH CSDMARD IN PATIENTS WITH MODERATE TO SEVERE RHEUMATOID ARTHRITIS: OBSERVATIONAL STUDY TO DESCRIBE REAL-WORLD DRUG RETENTION RATE AT 12 MONTHS. Annals of the rheumatic diseases. pp. 725-726. [Online].